Sirona Biochem Valuation
| SRBCF Stock | USD 0.05 0 9.89% |
Sirona Biochem seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Sirona Biochem Corp from inspecting the company fundamentals such as Return On Equity of -35.56, current valuation of 24.5 M, and Shares Owned By Insiders of 10.43 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sirona Biochem's price fluctuation is out of control at this time. Calculation of the real value of Sirona Biochem Corp is based on 3 months time horizon. Increasing Sirona Biochem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sirona pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Sirona Biochem Corp. Since Sirona Biochem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sirona Pink Sheet. However, Sirona Biochem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.05 | Real 0.0437 | Hype 0.05 |
The real value of Sirona Pink Sheet, also known as its intrinsic value, is the underlying worth of Sirona Biochem Corp Company, which is reflected in its stock price. It is based on Sirona Biochem's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sirona Biochem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sirona Biochem Corp helps investors to forecast how Sirona pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sirona Biochem more accurately as focusing exclusively on Sirona Biochem's fundamentals will not take into account other important factors: Sirona Biochem Total Value Analysis
Sirona Biochem Corp is at this time forecasted to have takeover price of 24.5 M with market capitalization of 20.74 M, debt of 468.77 K, and cash on hands of 1.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sirona Biochem fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.5 M | 20.74 M | 468.77 K | 1.13 M |
Sirona Biochem Investor Information
The company recorded a loss per share of 0.01. Sirona Biochem Corp had not issued any dividends in recent years. Sirona Biochem Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Sirona Biochem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sirona Biochem has an asset utilization ratio of 20.82 percent. This implies that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that Sirona Biochem Corp is more efficient with each dollar of assets it utilizes for everyday operations.Sirona Biochem Ownership Allocation
Sirona Biochem Corp shows a total of 251.73 Million outstanding shares. Sirona Biochem Corp has 10.43 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sirona Biochem Profitability Analysis
The company reported the revenue of 268.02 K. Net Loss for the year was (2.31 M) with profit before overhead, payroll, taxes, and interest of 199.25 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sirona Biochem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sirona Biochem and how it compares across the competition.
About Sirona Biochem Valuation
The pink sheet valuation mechanism determines Sirona Biochem's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sirona Biochem. We calculate exposure to Sirona Biochem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sirona Biochem's related companies.Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Sirona Biochem is traded on OTC Exchange in the United States.
8 Steps to conduct Sirona Biochem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sirona Biochem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sirona Biochem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sirona Biochem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sirona Biochem's revenue streams: Identify Sirona Biochem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sirona Biochem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sirona Biochem's growth potential: Evaluate Sirona Biochem's management, business model, and growth potential.
- Determine Sirona Biochem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sirona Biochem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Sirona Biochem Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sirona Biochem does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 236.1 M | |
| Retained Earnings | -37.8 M |
Complementary Tools for Sirona Pink Sheet analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |